Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee

NCT04369261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1949

Last updated 2020-04-30

No results posted yet for this study

Summary

This is an observational study to evaluate the injection site reactions of Synovian® Inj. in patients with osteoarthritis in the knee

Conditions

  • Osteoarthritis in the Knee

Interventions

DRUG

Synovian®

Synovian® Inj.

Sponsors & Collaborators

  • LG Chem

    lead INDUSTRY

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-09
Primary Completion
2019-08-08
Completion
2019-08-08

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04369261 on ClinicalTrials.gov